Stage 1 ET is manageable with early intervention, lifestyle changes, and treatments like low-dose aspirin and cytoreductive therapy to reduce clotting risk. Meta: Stage 1 essential thrombocythemia is ...

Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm (MPN) characterized by an increase in the number of platelets in the blood. Of the three main types of MPNs (ET, polycythemia ...

While in nursing school, a patient recognized potential signs of a blood disorder and advocated for further testing, leading to an early diagnosis of essential thrombocythemia. Despite initial ...

A recent study identified trends in blood counts, but did not find statistically significant associations between achieving hematological remission and clinical outcomes in polycythemia vera (PV) or ...

Rising global incidence of myeloproliferative diseases boosts demand for specialized treatments. Breakthroughs in JAK inhibitors and thrombopoietin receptor agonists enhance disease management. The ...

Hemorrhagic events post-diagnosis in patients with ET significantly increase mortality risk, more than thrombosis or disease progression. Intracranial hemorrhage is the most lethal bleeding ...

The initiation of a second Phase 3 clinical trial for bomedemstat demonstrates company’s commitment to advancing research in myeloproliferative neoplasms (MPNs) RAHWAY, N.J.--(BUSINESS WIRE)-- Merck ...

Please provide your email address to receive an email when new articles are posted on . In this video, Aaron T. Gerds, MD, MS, discussed treatment findings from a phase two study presented at ASH ...

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study The Oncology Grand ...